Filing Details

Accession Number:
0001562180-19-000863
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-08 19:14:30
Reporting Period:
2019-02-06
Accepted Time:
2019-02-08 19:14:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100412 Array Biopharma Inc ARRY Pharmaceutical Preparations (2834) 841460811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191818 Kyle Lefkoff C/O Boulder Ventures
1941 Pearl Street, Suite 300
Boulder CO 80302
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-06 25,000 $10.47 47,720 No 4 M Direct
Common Stock Disposition 2019-02-06 25,000 $20.51 22,720 No 4 S Direct
Common Stock Disposition 2019-02-06 5,000 $20.82 25,000 No 4 S Indirect See footnote
Common Stock Disposition 2019-02-06 5,000 $20.85 20,000 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-02-06 25,000 $0.00 25,000 $10.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-10-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,000 Indirect See footnote
Footnotes
  1. The price reported for these shares is the weighted average sale price of transactions made at prices from $20.50 to $20.58. Details of actual prices for shares sold are available from the Reporting Person upon request.
  2. The sale was made by the Reporting Person as custodian for his son under the Colorado Uniform Gifts to Minors Act.
  3. The price reported for these shares is the weighted average sale price of transactions made at prices from $20.785 to $20.834. Details of actual prices for shares sold are available from the Reporting Person upon request.
  4. Comprised of shares of common stock in trust for the benefit of the Reporting Person's minor children.
  5. The price reported for these shares is the weighted average sale price of transactions made at prices from $20.805 to $20.864. Details of actual prices for shares sold are available from the Reporting Person upon request.
  6. Comprised of common stock held by BV Partners III Profit Sharing account for the benefit of the Reporting Person.
  7. The options vested on October 26, 2018.